Receiving a cancer diagnosis often prompts patients and families to seek as many options as possible. Some consider cancer treatment abroad to obtain a second opinion, consult doctors with particular subspecializations, or find out whether there are other treatment options relevant to the patient's condition.
However, seeking treatment abroad does not automatically provide better care. The right country or hospital for one patient may not be suitable for another. The type of cancer, stage, pathology results, biomarkers, health condition, treatments already undergone, and treatment goals need to be understood before comparing destinations.
Time is also an important consideration. In certain situations, delaying therapy to arrange travel can actually harm the patient. Therefore, the decision to seek treatment abroad should be made based on clinical needs, not merely the reputation of a country or the technology offered. This guide discusses when cancer treatment abroad may be considered, how to choose a country, doctor and hospital, the types of therapies available, the role of second opinions, costs that need to be calculated, and how to continue care after returning to Indonesia.
Why Do Patients Consider Cancer Treatment Abroad?
Each patient's reasons differ. Some want to confirm their diagnosis and treatment plan through a second opinion, while other patients need doctors with experience in more specific types of cancer.
For cancers that are relatively rare or have certain characteristics, a doctor's subspecialization can be an important consideration. Patients may want to seek cancer centers that more frequently treat that disease or have a multidisciplinary team with the required expertise.
Access to certain technologies or therapies can also be a reason. Some facilities may have radiotherapy techniques, surgical procedures, molecular testing, or specific medications that are not yet widely available elsewhere. However, the availability of technology does not mean every patient needs that technology.
There are also non-medical considerations such as proximity to family, language, travel distance, previous experience with hospitals, and the ability to undergo long-term treatment. Therefore, the more appropriate question is not "which country is best for cancer?" but "where are the doctors, facilities, and treatment options most relevant to my condition available?"
When Should Treatment Not Be Delayed to Go Abroad?
Seeking additional options can be beneficial, but time must not be overlooked. Some cancer conditions or their complications require more rapid intervention. Patients with bleeding, severe infection, respiratory distress, uncontrolled pain, organ obstruction, or unstable medical conditions may need immediate treatment at the nearest facility before considering travel.
Certain types of cancer can also progress more rapidly than others. Therefore, patients should ask their doctor whether there is a safe window of time to seek a second opinion or arrange treatment in another country.
Physical fitness for travel also needs to be assessed. Patients who have recently undergone surgery, have a risk of blood clots, require oxygen, or are experiencing certain complications may not yet be safe to fly.
If the condition requires time-sensitive therapy, do not delay simply because you are waiting for an appointment abroad. Discuss whether a second opinion can be obtained through medical record review first without delaying needed care.
Also read: Medical Tourism Indonesia: Panduan Berobat ke Luar Negeri
Understand the Diagnosis Before Choosing a Country
One mistake that can occur is choosing a country or hospital first before fully understanding the diagnosis. Terms like "lung cancer," "breast cancer," or "blood cancer" are still too broad to determine treatment. Two patients with cancer in the same organ can have different disease characteristics and treatment options.
Before comparing cancer treatment abroad, some important information that needs to be known includes:
- type of cancer
- histopathological subtype
- stage
- location and extent of spread
- biomarker or molecular testing results if relevant
- patient's health condition
- surgery or treatments already performed
- response to previous therapy
Biopsy results and pathology reports are critically important because treatment options often depend on the characteristics of the cancer tissue. For some types of cancer, biomarker testing can determine whether a patient may benefit from targeted therapy, immunotherapy, or hormonal therapy.
Treatment goals also need to be understood. For some patients, therapy aims to eliminate the cancer. In other situations, the primary goal may be to control the disease, prolong survival, reduce symptoms, or maintain quality of life. With this information, the search for hospitals and doctors can become far more focused.
Cancer Treatment Options That May Be Considered
Cancer treatment does not only mean chemotherapy. Depending on the diagnosis, patients may need one therapy or a combination of several types of treatment.
Cancer Surgery
Surgery aims to remove the tumor or cancer-affected tissue in certain conditions. Its suitability depends on the tumor location, stage, relationship with surrounding structures, and the patient's condition.
Some cancers can be treated primarily through surgery, whereas for other cancers patients need chemotherapy or radiotherapy before or after the procedure.
Minimally invasive techniques or robotic-assisted surgery are available for some procedures at certain facilities. However, newer techniques do not automatically provide better results for every patient. The doctor's experience and the suitability of the procedure remain key considerations.
Chemotherapy
Chemotherapy uses drugs to kill or inhibit the growth of cancer cells. Drugs can be administered via infusion, injection, or orally depending on the regimen.
Chemotherapy can be given before surgery to shrink tumours, after surgery to reduce the risk of recurrence, concurrently with radiotherapy, or as primary therapy for certain cancers. The cost and duration cannot be determined solely from the word "chemotherapy". The type of drug, dose, number of cycles, patient's body weight, as well as drug combinations can affect the overall plan.
Radiotherapy
Radiotherapy uses radiation to damage cancer cells in a specific area. Techniques may include external beam radiation therapy, IMRT, VMAT, SBRT, stereotactic radiosurgery, or brachytherapy depending on the location and type of cancer.
The most complex radiotherapy technology is not always the best option. Doctors need to determine the technique that can deliver the required dose to the tumour while limiting exposure to surrounding healthy tissue. The number of sessions also differs. Some therapies are performed in a few sessions, while other conditions require a course of therapy over several weeks.
Targeted Therapy
Targeted therapy works against specific molecular targets or pathways that help cancer growth. Therefore, this therapy is not given based solely on the cancer name. In many conditions, doctors require biomarker or molecular testing to determine whether the tumour has the relevant target.
If a patient is considering targeted therapy abroad, ask what test results form the basis of the recommendation and whether the drug is indeed indicated for the type of cancer being treated.
Immunotherapy
Immunotherapy helps the immune system recognise or fight cancer cells through specific mechanisms. This therapy has become an important part of treatment for some types of cancer, but is not suitable for all patients. Cancer type, stage, biomarkers, prior therapy, as well as health condition can affect the decision.
Immunotherapy also has side effects that differ from chemotherapy because activation of the immune system can cause inflammation in certain organs. Therefore, patients need to understand not only the potential benefits but also how side effects will be monitored and managed.
Hormonal Therapy
Hormonal therapy is used for certain cancers whose growth is influenced by hormones, particularly some breast and prostate cancers. Testing of tumour characteristics helps determine whether this approach is relevant.
Therapy can last for the long term, so drug costs, monitoring, and follow-up need to be included in planning, not just the initial treatment costs.
Transplantation for Specific Indications
Transplantation is not a common cancer therapy, but can be considered in certain conditions.
Some blood cancers may require stem cell or bone marrow transplantation in patients who meet the criteria. For certain liver cancers, liver transplantation may be an option if the patient meets strict selection criteria. Transplantation requires specific evaluation and cannot be decided based solely on a cancer diagnosis.
Supportive and Palliative Care
Cancer care does not only aim to attack the tumour. Supportive care helps address problems such as pain, nausea, fatigue, nutritional disturbances, infection, or therapy side effects.
Palliative care can also be given concurrently with cancer treatment to help control symptoms and maintain quality of life. Palliative care does not always mean all cancer therapy is stopped.
When comparing cancer centres, support for symptoms and quality of life is also worth considering alongside treatment technology.
How to Choose a Country for Cancer Treatment?
There is no single country that is always the best choice for all cancers. Malaysia may be relevant for Indonesian patients due to distance and available cancer centre options. Singapore has cancer centres and certain subspecialist services. Other countries can be considered if there are more specific clinical needs.
However, comparing countries based only on national reputation is less helpful compared to comparing facilities based on patient needs.
Consider:
- available doctors and subspecialisations
- centre experience in treating the cancer type
- diagnostic facilities
- access to required surgery, radiotherapy, or systemic therapy
- multidisciplinary team approach
- drug availability
- possibility of clinical trials if relevant
- communication language
- distance from Indonesia
- visa and travel requirements
- overall costs
- ability to conduct follow-up
If therapy lasts several months, distance and ease of travel can become far more important factors compared to patients who are only seeking a one-time second opinion.
How to Choose a Hospital and Cancer Doctor?
Start from the disease, not from hospital popularity. If a patient has breast cancer, look for doctors and centres that treat breast cancer. If the diagnosis is leukaemia, a centre with haematology and haemato-oncology services is more relevant compared to simply a hospital with a "cancer centre" label.
Also check whether the required facilities are available. Patients who may require radiotherapy, for example, need to know whether therapy can be performed at the same hospital or must be referred elsewhere.
In complex cases, the presence of a multidisciplinary team can help because decisions can involve a medical oncologist, radiation oncologist, surgeon, radiologist, pathologist, and other specialists.
When evaluating doctors, consider:
- specialisation and subspecialisation
- types of cancer that are the clinical focus
- hospital where they practise
- therapies managed
- involvement in MDT
- communication ability
- follow-up mechanism
Avoid choosing based solely on claims of "best cancer doctor". The right doctor is one with expertise relevant to the patient's condition.
When Is a Second Opinion Useful?
A second opinion can help when a new diagnosis is established, the patient is facing major surgery, there are several treatment options, or the patient wants to confirm a plan before starting treatment.
A second opinion can also be useful for rare cancers, when pathology results are difficult to interpret, or when the disease does not respond as expected to previous therapy.
The goal is not always to get a different recommendation. The second doctor may confirm the diagnosis and plan already given, which is also valuable information for the patient.
To obtain a quality second opinion, prepare:
- biopsy and histopathology reports
- slides or tissue blocks if requested
- CT, MRI, or PET-CT
- original imaging files if available
- laboratory results
- biomarker results
- surgical reports
- chemotherapy regimens or previous therapies
- medication list
- medical summary
In some cases, documents can be reviewed before the patient departs. However, final recommendations may still require direct examination or additional tests.
Do Biopsy Results Need to Be Re-examined?
Not always, but pathology review can be considered in certain situations. Pathology is the basis of diagnosis for many types of cancer. Differences in tumor subtypes or characteristics can affect treatment choices.
Review may be more relevant if the diagnosis is unclear, the cancer is a rare type, pathology results do not match the clinical picture, or major treatment decisions depend on specific tissue details.
Overseas hospitals may also request original slides or tissue blocks to perform additional testing or biomarker testing. Before sending pathology material, ask about shipping procedures, required documents, and how samples will be returned.
How to Compare Cancer Treatment Costs Abroad?
Do not compare just one "cancer treatment price" figure. Costs differ based on cancer type, stage, therapy, medications, hospital, and duration of care. Even two patients with the same diagnosis can have different total costs because their regimens and examination needs are not the same.
Calculation should include:
- consultations
- pathology review
- laboratory tests
- CT, MRI, PET-CT, or other imaging
- biomarker testing
- surgery
- anesthesia
- hospitalization
- chemotherapy per cycle
- radiotherapy as one treatment course
- targeted therapy
- immunotherapy
- supportive medications
- side effect management
- follow-up
- travel
- accommodation
- companion costs
Systemic therapy can also last for months. Therefore, do not only ask for the price of one drug cycle if the patient is expected to need several cycles. Also ask what happens if the dose changes, therapy is delayed due to side effects, or the patient needs hospitalization. Cost estimates should be seen as an initial plan, not a guarantee that the final total will not change.
Clinical Trials and Experimental Therapies
Some patients seek cancer treatment abroad because they are interested in clinical trials or therapies not yet widely available.
Clinical trials are structured research to evaluate medical interventions. Trials have very specific patient criteria based on cancer type, stage, biomarkers, previous therapies, organ condition, and other factors. Therefore, the existence of a trial does not mean patients can automatically participate.
Patients need to understand:
- research phase
- trial objectives
- therapy being tested
- comparator therapy if any
- eligibility criteria
- known and unknown risks
- required examinations
- what costs are covered by the research
- what costs remain the patient's responsibility
- travel and follow-up requirements
Participation must also go through an informed consent process. Beware of parties that market experimental therapies as if they are proven treatments or promise specific results. Trials should not be understood as a guarantee of cure.
How to Know If a Therapy Has Been Approved?
If a doctor offers unfamiliar medications or technology, patients can ask about its usage status.
Questions that can be asked include:
- Has this therapy been approved for my type of cancer?
- Which regulator granted approval?
- Is this use on-label or off-label?
- What clinical evidence supports it?
- Is this therapy part of a clinical trial?
- What are the standard options besides this therapy?
Off-label use does not automatically mean the therapy is inappropriate. In oncology, certain drugs can be used based on scientific evidence even if their regulatory indication differs. However, patients need to know the reason for its use and available alternatives.
Do not rely on marketing materials or social media as the sole source regarding cancer therapy effectiveness.
Planning Continuity of Care with Doctors in Indonesia
Source: https://www.pexels.com/id-id/foto/klinik-rsud-lorong-koridor-11660581/
One of the most important aspects of cross-border treatment is what happens after the patient returns. Before going home, request complete medical documents such as:
- diagnosis summary
- pathology reports
- imaging results
- surgical reports
- chemotherapy regimens
- radiotherapy details
- medication list
- biomarker results
- side effects that have occurred
- monitoring plan
- follow-up schedule
If possible, ask whether some therapies or examinations can be continued in Indonesia. For example, patients may receive surgery or treatment planning abroad but undergo some monitoring in Indonesia. In other conditions, certain drug regimens may be available in both countries so patients do not have to travel every time.
However, decisions like this must be coordinated between doctors. Do not switch or stop therapy on your own just to reduce travel needs. Good continuity of care helps ensure doctors in Indonesia understand what has been done and doctors abroad know the patient's progress after returning.
Before going home, patients should also know who to contact if side effects or complications arise. For conditions requiring immediate attention, patients still need to seek the nearest medical help in Indonesia and not wait for consultation with the overseas hospital.
Good coordination from the start can also influence the choice of country and hospital. If therapy is expected to last for months, ask whether some blood tests, medication administration, rehabilitation, or follow-ups can be done in Indonesia without disrupting the treatment plan.
How Medifly Helps Patients Seek Cancer Treatment Abroad?
Comparing cancer treatment across multiple countries can be complicated because patients need to search not only for hospitals, but also for doctors with the right subspecialization, required facilities, therapy options, cost estimates, and follow-up mechanisms.
Medifly helps Indonesian patients navigate this process by searching for doctors and hospitals in its network based on the patient's condition and care needs.
The process can begin by gathering information such as:
- diagnosis already given
- pathology report
- CT, MRI, or PET-CT results
- biomarker or molecular testing results
- surgical history
- chemotherapy or radiotherapy already undergone
- medication list
- purpose of consultation or second opinion
With more complete information, the search can be directed to more relevant doctors and facilities rather than just choosing a country based on reputation.
Medifly can assist in processes such as:
- searching for doctors and hospitals based on cancer type
- comparing options across multiple countries
- helping prepare and send medical records
- arranging appointments
- assisting with the second opinion process
- requesting information about cost estimates
- helping with hospital communications
- coordinating travel and accommodation
- assisting with the follow-up process after treatment
If the patient does not yet know which country to choose, the search can start from clinical needs first. After that, country options can be compared based on doctors, facilities, available therapies, costs, travel distance, and monitoring requirements.
Medifly assists with the search and coordination process, but does not determine diagnosis or select cancer therapy for patients. Clinical recommendations remain provided by the doctor evaluating the patient's condition.
Also read: Medical Concierge Indonesia: Pendamping Berobat ke Luar Negeri | Medifly
Conclusion
Cancer treatment abroad can be considered when patients need a second opinion, a doctor with a specific subspecialization, relevant facilities or therapies, or want to compare several options before making a major decision.
However, the country with the most technology or the most famous hospital is not necessarily the most appropriate choice for every patient. The first step should be to understand the cancer type, stage, pathology results, biomarkers, therapies already performed, and treatment goals.
After that, patients can compare countries and cancer centers based on doctors, experience in treating that cancer type, facilities, multidisciplinary approach, therapy options, total costs, and the ability to conduct follow-up after returning to Indonesia.
Time is also important. If the cancer or its complications require immediate treatment, do not delay therapy just to arrange travel. Ask the doctor whether there is sufficient time to seek a second opinion or whether medical record review can be done first.
Finally, the treatment plan should not stop when the patient leaves the overseas hospital. Ensure there is a medical summary, monitoring plan, medication information, and coordination mechanism with doctors in Indonesia so that care can continue safely.
Need Help Comparing Cancer Treatment Abroad?
Medifly can help you search for doctors and hospitals in the network based on cancer type and care needs, prepare medical records, arrange consultations, and coordinate medical travel.
References:
National Cancer Institute – Cancer Treatment
